Trexquant Investment’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-92,389
Closed -$700K 1145
2020
Q1
$700K Buy
+92,389
New +$700K 0.05% 533
2019
Q1
Sell
-54,593
Closed -$302K 962
2018
Q4
$302K Buy
+54,593
New +$302K 0.02% 777
2018
Q3
Sell
-35,822
Closed -$358K 927
2018
Q2
$358K Buy
+35,822
New +$358K 0.02% 630
2018
Q1
Sell
-21,102
Closed -$314K 1041
2017
Q4
$314K Buy
21,102
+3,496
+20% +$52K 0.03% 727
2017
Q3
$346K Buy
+17,606
New +$346K 0.09% 412
2017
Q2
Sell
-17,220
Closed -$158K 764
2017
Q1
$158K Sell
17,220
-15,814
-48% -$145K 0.02% 997
2016
Q4
$344K Buy
+33,034
New +$344K 0.05% 593
2016
Q3
Sell
-32,442
Closed -$243K 711
2016
Q2
$243K Buy
+32,442
New +$243K 0.03% 724
2016
Q1
Sell
-44,200
Closed -$571K 886
2015
Q4
$571K Sell
44,200
-28,300
-39% -$366K 0.05% 630
2015
Q3
$700K Buy
+72,500
New +$700K 0.06% 583